Clinical Trials Logo

Clinical Trial Summary

Cannabis is the most commonly used illicit drug in the United States, and its use is associated with rates of development of abuse and dependence, treatment admission and relapse that are comparable to other illicit drugs. Currently there is no effective pharmacological treatment for cannabis-use disorders. The purpose of the present study is to evaluate the ability of pregabalin to reduce cannabis use thereby evaluating its effectiveness as a medication for cannabis-use disorders.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT01511640
Study type Interventional
Source University of Kentucky
Contact
Status Completed
Phase Early Phase 1
Start date February 1, 2017
Completion date March 15, 2020